Beam Therapeutics
BEAM
#4050
Rank
NZ$4.97 B
Marketcap
NZ$49.02
Share price
5.59%
Change (1 day)
4.43%
Change (1 year)

Market capitalization of Beam Therapeutics (BEAM)

Market cap: NZ$4.97 Billion

As of January 2026 Beam Therapeutics has a market cap of NZ$4.97 Billion. This makes Beam Therapeutics the world's 4050th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Beam Therapeutics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$4.97 B1.46%
2025NZ$4.90 B25.57%
2024NZ$3.90 B11.29%
2023NZ$3.50 B-19.18%
2022NZ$4.34 B-45.39%
2021NZ$7.94 B21.2%
2020NZ$6.55 B

End of Day market cap according to different sources

On Jan 5th, 2026 the market cap of Beam Therapeutics was reported to be:

NZ$4.71 Billion
by Nasdaq info icon info icon
NZ$4.71 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ$1.37 B-72.43%๐Ÿ‡บ๐Ÿ‡ธ USA